We used a non-targeted global metabolomic approach to gain insight into mechanisms controlling C20-22 n-3 PUFA attenuation of WD-induced NASH in LDLR-/- mice. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatohepatitis.